BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23889553)

  • 1. An extended pyrrolobenzodiazepine-polyamide conjugate with selectivity for a DNA sequence containing the ICB2 transcription factor binding site.
    Brucoli F; Hawkins RM; James CH; Jackson PJ; Wells G; Jenkins TC; Ellis T; Kotecha M; Hochhauser D; Hartley JA; Howard PW; Thurston DE
    J Med Chem; 2013 Aug; 56(16):6339-51. PubMed ID: 23889553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the inverted CCAAT box 2 in the topoisomerase IIalpha promoter by JH-37, an imidazole-pyrrole polyamide hairpin: design, synthesis, molecular biology, and biophysical studies.
    Henry JA; Le NM; Nguyen B; Howard CM; Bailey SL; Horick SM; Buchmueller KL; Kotecha M; Hochhauser D; Hartley JA; Wilson WD; Lee M
    Biochemistry; 2004 Sep; 43(38):12249-57. PubMed ID: 15379563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of an intercalator-polyamide hairpin designed to target the inverted CCAAT box 2 in the topoisomerase IIalpha promoter.
    Flores LV; Staples AM; Mackay H; Howard CM; Uthe PB; Sexton JS; Buchmueller KL; Wilson WD; O'Hare C; Kluza J; Hochhauser D; Hartley JA; Lee M
    Chembiochem; 2006 Nov; 7(11):1722-9. PubMed ID: 16991167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of topoisomerase IIα expression and chemosensitivity through targeted inhibition of NF-Y:DNA binding by a diamino p-anisyl-benzimidazole (Hx) polyamide.
    Pett L; Kiakos K; Satam V; Patil P; Laughlin-Toth S; Gregory M; Bowerman M; Olson K; Savagian M; Lee M; Lee M; Wilson WD; Hochhauser D; Hartley JA
    Biochim Biophys Acta Gene Regul Mech; 2017 May; 1860(5):617-629. PubMed ID: 27750031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of DNA binding of the NF-Y transcription factor by the pyrrolobenzodiazepine-polyamide conjugate GWL-78.
    Kotecha M; Kluza J; Wells G; O'Hare CC; Forni C; Mantovani R; Howard PW; Morris P; Thurston DE; Hartley JA; Hochhauser D
    Mol Cancer Ther; 2008 May; 7(5):1319-28. PubMed ID: 18483319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA sequence-selective C8-linked pyrrolobenzodiazepine-heterocyclic polyamide conjugates show anti-tubercular-specific activities.
    Brucoli F; Guzman JD; Basher MA; Evangelopoulos D; McMahon E; Munshi T; McHugh TD; Fox KR; Bhakta S
    J Antibiot (Tokyo); 2016 Dec; 69(12):843-849. PubMed ID: 27168314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design of a hairpin polyamide, ZT65B, for targeting the inverted CCAAT box (ICB) site in the multidrug resistant (MDR1) gene.
    Buchmueller KL; Taherbhai Z; Howard CM; Bailey SL; Nguyen B; O'Hare C; Hochhauser D; Hartley JA; Wilson WD; Lee M
    Chembiochem; 2005 Dec; 6(12):2305-11. PubMed ID: 16254941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel C8-linked pyrrolobenzodiazepine (PBD)-heterocycle conjugates that recognize DNA sequences containing an inverted CCAAT box.
    Brucoli F; Hawkins RM; James CH; Wells G; Jenkins TC; Ellis T; Hartley JA; Howard PW; Thurston DE
    Bioorg Med Chem Lett; 2011 Jun; 21(12):3780-3. PubMed ID: 21570842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of topoisomerase IIalpha expression by a DNA sequence-specific polyamide.
    Hochhauser D; Kotecha M; O'hare C; Morris PJ; Hartley JM; Taherbhai Z; Harris D; Forni C; Mantovani R; Lee M; Hartley JA
    Mol Cancer Ther; 2007 Jan; 6(1):346-54. PubMed ID: 17237293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the inverted CCAAT Box-2 of the topoisomerase IIalpha gene: DNA sequence selective recognition by a polyamide-intercalator as a staggered dimer.
    Mackay H; Brown T; Sexton JS; Kotecha M; Nguyen B; Wilson WD; Kluza J; Savic B; O'Hare C; Hochhauser D; Lee M; Hartley JA
    Bioorg Med Chem; 2008 Feb; 16(4):2093-102. PubMed ID: 17977733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the ICB2 site of the topoisomerase IIalpha promoter with a formamido-pyrrole-imidazole-pyrrole H-pin polyamide.
    Franks A; Tronrud C; Kiakos K; Kluza J; Munde M; Brown T; Mackay H; Wilson WD; Hochhauser D; Hartley JA; Lee M
    Bioorg Med Chem; 2010 Aug; 18(15):5553-61. PubMed ID: 20615712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear Localization and Gene Expression Modulation by a Fluorescent Sequence-Selective p-Anisyl-benzimidazolecarboxamido Imidazole-Pyrrole Polyamide.
    Kiakos K; Pett L; Satam V; Patil P; Hochhauser D; Lee M; Hartley JA
    Chem Biol; 2015 Jul; 22(7):862-75. PubMed ID: 26119998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the human topoisomerase IIbeta (TOP2B) promoter activity: essential roles of the nuclear factor-Y (NF-Y)- and specificity protein-1 (Sp1)-binding sites.
    Lok CN; Lang AJ; Mirski SE; Cole SP
    Biochem J; 2002 Dec; 368(Pt 3):741-51. PubMed ID: 12197834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of DNA topoisomerase II alpha promoter activity by members of the Sp (specificity protein) and NF-Y (nuclear factor Y) families of transcription factors.
    Magan N; Szremska AP; Isaacs RJ; Stowell KM
    Biochem J; 2003 Sep; 374(Pt 3):723-9. PubMed ID: 12769819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the Op18 gene is maintained by the CCAAT-binding transcription factor NF-Y.
    Benlhabib H; Herrera JE
    Gene; 2006 Aug; 377():177-85. PubMed ID: 16757134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor-Y binding to the topoisomerase IIalpha promoter is inhibited by both the p53 tumor suppressor and anticancer drugs.
    Joshi AA; Wu Z; Reed RF; Suttle DP
    Mol Pharmacol; 2003 Feb; 63(2):359-67. PubMed ID: 12527807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequence-selective binding of C8-conjugated pyrrolobenzodiazepines (PBDs) to DNA.
    Basher MA; Rahman KM; Jackson PJM; Thurston DE; Fox KR
    Biophys Chem; 2017 Nov; 230():53-61. PubMed ID: 28941814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and biophysical and biological evaluation of a series of pyrrolobenzodiazepine-poly(N-methylpyrrole) conjugates.
    Wells G; Martin CR; Howard PW; Sands ZA; Laughton CA; Tiberghien A; Woo CK; Masterson LA; Stephenson MJ; Hartley JA; Jenkins TC; Shnyder SD; Loadman PM; Waring MJ; Thurston DE
    J Med Chem; 2006 Sep; 49(18):5442-61. PubMed ID: 16942018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GC-targeted C8-linked pyrrolobenzodiazepine-biaryl conjugates with femtomolar in vitro cytotoxicity and in vivo antitumor activity in mouse models.
    Rahman KM; Jackson PJ; James CH; Basu BP; Hartley JA; de la Fuente M; Schatzlein A; Robson M; Pedley RB; Pepper C; Fox KR; Howard PW; Thurston DE
    J Med Chem; 2013 Apr; 56(7):2911-35. PubMed ID: 23514599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of f-PIP, a pyrrole- and imidazole-containing triamide, to the inverted CCAAT box-2 of the topoisomerase IIalpha promoter and modulation of gene expression in cells.
    Le NM; Sielaff AM; Cooper AJ; Mackay H; Brown T; Kotecha M; O'Hare C; Hochhauser D; Lee M; Hartley JA
    Bioorg Med Chem Lett; 2006 Dec; 16(24):6161-4. PubMed ID: 17011187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.